Q. Who will be first to take first mover advantage in genomic based vaccines to the masses (patients)?
That is, the first academic medical center to drop conventional cancer chemo therapy for genomic based vaccine immunotherapy.
Q. What will happen to the rest of the cancer centers that fail to adopt the new paradigm of treatment?
Q. At what stage will the medical centers recognize the fast approaching inflection point that they are irrelevant and need to change toward genomic based vaccine immunology or risk losing all of their patients?
Q. What will the inflection point be that tips the scale toward the new paradigm and they begin to move toward genomics? Actionable items: they will need to endow a chairmanship position, raise money and reorganize by bringing in the best and brightest practitioners and researchers, and find support for future funding in genomics.
Q. Has the first shot been fired? Fired by Sloan Kettering, partnered with Juno Therapeutic ($120 million venture capital raised and launched December 4, 2013) and Univ. of Penn, together they are curing patients of leukemia. The shot heard around the world! Yes, they fired it. The public got to see the patients and hear them speak about a life saving cure.
Q. Who else is still back stage and waiting for the curtain call? Waiting to shine in the public domain and show their stuff (vaccine trials) and demonstrate outcomes? We see a lot of big pharmaceutical players reorganizing. I am just as excited as my fellow longs here, you have the vision to see very early, the tidal wave of change that is sweeping the health care field in genomic vaccine immunology. You already know the answer to this last question. This has to be the year of Inovio. Stay the course, do not be distracted by the bashers. We were advised, 2014 will dwarf 2013. Believe it!
Yes: The oncology practice of today's medical centers will be replaced with Inovio's Syncon based vaccine therapies. Nice post Vid... you raised some good questions tonight. Let the paradigm shift begin and save lives and prevent diseases.
Hey Video, shout out to you for this tip. I got it back in December on the MVIS board and I don't know if I thanked you yet. Lots of real facts to use as opposed to the other side. Great management here and quality everywhere you look. Thanks again and keep the faith. I'm a Philly guy living in Maryland, but I know about all the advancements in the medical arena going on there. I have hit a good one in INCY and I think I may have mentioned that on the other board. Good to read your posts.
INO may not be the first but with the mile long pipeline and electroporation , INO is poised to race way past the other horses.
I am sure the resistance to dumping all the pricey, ineffective and even deadly apparatus of conventional chemo therapy will hardly be enough to stop the shift.
Bashers can be distracting but encouraging. The mere fact that hedge funds actually pay these guys to cast fear , uncertainty and doubt tells me they are also smitten by INO. Certainly it isn't to protect Ole Mom and Pop.